Onya Therapeutics
Onya Therapeutics is a biotech startup based in Wales, UK, focused on developing novel wound care therapies. Their mission is to reduce the use of antibiotics in wound care and combat antimicrobial resistance. They are dedicated to creating advanced wound healing technologies that improve patient outcomes and quality of life.
Industries
Nr. of Employees
small (1-50)
Onya Therapeutics
The Innovation Centre, Festival Drive, Ebbw Vale, Blaenau Gwent NP23 8XA
Patents
Patch comprising potassium permanganate for the treatment of skin disorder
US-11129800-B2
View Details
Patch comprising potassium permanganate for the treatment of skin disorder
US-11129800-B2
View DetailsProducts
Targeted controlled-release wound dressing for excess exudate
A patented patch-format dressing that delivers a known active compound locally to manage excess wound exudate, with the aim of accelerating healing and reducing dressing change frequency.
Controlled-release patch for high-risk acute wounds
A patch-formulation designed for acute traumatic wounds at high risk of infection, engineered for targeted sustained release and extended wear time.
Topical therapeutic for infected wounds (alternative to antibiotics)
A topically applied therapeutic intended to treat infected wounds using locally available active agents as an alternative to systemic antibiotics.
Targeted controlled-release wound dressing for excess exudate
A patented patch-format dressing that delivers a known active compound locally to manage excess wound exudate, with the aim of accelerating healing and reducing dressing change frequency.
Controlled-release patch for high-risk acute wounds
A patch-formulation designed for acute traumatic wounds at high risk of infection, engineered for targeted sustained release and extended wear time.
Topical therapeutic for infected wounds (alternative to antibiotics)
A topically applied therapeutic intended to treat infected wounds using locally available active agents as an alternative to systemic antibiotics.
Services
Collaborative research and development projects with academic institutions and industry partners to advance wound care technologies.
Provision of clinical expertise and advisory board input to inform clinical strategy, endpoint selection and trial design for wound care studies.
Project and programme management services focused on translating laboratory technologies into scalable commercial products, including technical and regulatory coordination.
Collaborative research and development projects with academic institutions and industry partners to advance wound care technologies.
Provision of clinical expertise and advisory board input to inform clinical strategy, endpoint selection and trial design for wound care studies.
Project and programme management services focused on translating laboratory technologies into scalable commercial products, including technical and regulatory coordination.
Expertise Areas
- Wound care therapeutics development
- Topical drug delivery and patch systems
- Antivirulence antimicrobial research
- Pre-clinical development and safety assessment
Key Technologies
- Controlled-release topical patch delivery
- Targeted local drug delivery for wounds
- Quorum sensing and virulence inhibition approaches
- Topical formulation engineering
News & Updates
We welcomed Professor Keith Harding, an internationally recognised leader in wound care, and Dr David Houston from Transdiagen, for a day of collaboration and shared innovation.
Onya Therapeutics has moved into new laboratories and offices at The Innovation Centre in Ebbw Vale.
Onya Therapeutics was established as a spin-out from Neem Biotech, focusing on products for hard-to-treat and chronic wounds, with lead product PP01 for overly exuding wounds.
We welcomed Professor Keith Harding, an internationally recognised leader in wound care, and Dr David Houston from Transdiagen, for a day of collaboration and shared innovation.
Onya Therapeutics has moved into new laboratories and offices at The Innovation Centre in Ebbw Vale.
Onya Therapeutics was established as a spin-out from Neem Biotech, focusing on products for hard-to-treat and chronic wounds, with lead product PP01 for overly exuding wounds.